Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550925 · ClinicalTrials.gov registry record · NA
Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT02550925: Completed NA study, sponsored by University of Colorado, Boulder.
NCT02550925 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 139 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02550925, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
Primary Outcome
Method of assessment: questionnaire
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Acceptance and Commitment Therapy (ACT) Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT02550925 record still lists
NCT02550925 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02550925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02550925 about?
NCT02550925 is a clinical study titled "Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors". This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
What is the current status of trial NCT02550925?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2015-09. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02550925?
The interventions under investigation include: Usual Care (BEHAVIORAL), Acceptance and Commitment Therapy (ACT) Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02550925?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02550925's enrollment target sits among peer trials
139 720th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia